Case Reports
doi: 10.1136/bmj.b1223.Experimental vaccine may have saved Hamburg scientist from Ebola fever
- PMID:19307268
- DOI: 10.1136/bmj.b1223
Item in Clipboard
Case Reports
Experimental vaccine may have saved Hamburg scientist from Ebola fever
Annette Tuffs. BMJ..
Display options
Format
Display options
Format
No abstract available
Similar articles
- Management of accidental exposure to Ebola virus in the biosafety level 4 laboratory, Hamburg, Germany.Günther S, Feldmann H, Geisbert TW, Hensley LE, Rollin PE, Nichol ST, Ströher U, Artsob H, Peters CJ, Ksiazek TG, Becker S, ter Meulen J, Olschläger S, Schmidt-Chanasit J, Sudeck H, Burchard GD, Schmiedel S.Günther S, et al.J Infect Dis. 2011 Nov;204 Suppl 3:S785-90. doi: 10.1093/infdis/jir298.J Infect Dis. 2011.PMID:21987751
- Emergency treatment for exposure to Ebola virus: the need to fast-track promising vaccines.Geisbert TW.Geisbert TW.JAMA. 2015 Mar 24-31;313(12):1221-2. doi: 10.1001/jama.2015.2057.JAMA. 2015.PMID:25742306No abstract available.
- A DNA vaccine for the prevention of Ebola virus infection.Dery M, Bausch DG.Dery M, et al.Curr Opin Mol Ther. 2008 Jun;10(3):285-93.Curr Opin Mol Ther. 2008.PMID:18535936
- Treatment of Marburg and Ebola hemorrhagic fevers: a strategy for testing new drugs and vaccines under outbreak conditions.Bausch DG, Sprecher AG, Jeffs B, Boumandouki P.Bausch DG, et al.Antiviral Res. 2008 Apr;78(1):150-61. doi: 10.1016/j.antiviral.2008.01.152. Epub 2008 Feb 26.Antiviral Res. 2008.PMID:18336927Review.
- [Ebola and Marburg hemorrhagic fever viruses: update on filoviruses].Leroy E, Baize S, Gonzalez JP.Leroy E, et al.Med Trop (Mars). 2011 Apr;71(2):111-21.Med Trop (Mars). 2011.PMID:21695865Review.French.
Cited by
- A call to action to enhance filovirus disease outbreak preparedness and response.Roddy P.Roddy P.Viruses. 2014 Sep 30;6(10):3699-718. doi: 10.3390/v6103699.Viruses. 2014.PMID:25271875Free PMC article.
- Ebola haemorrhagic fever.Feldmann H, Geisbert TW.Feldmann H, et al.Lancet. 2011 Mar 5;377(9768):849-62. doi: 10.1016/S0140-6736(10)60667-8.Lancet. 2011.PMID:21084112Free PMC article.Review.
- Comparative pathogenesis and systems biology for biodefense virus vaccine development.Bowick GC, Barrett AD.Bowick GC, et al.J Biomed Biotechnol. 2010;2010:236528. doi: 10.1155/2010/236528. Epub 2010 Jun 6.J Biomed Biotechnol. 2010.PMID:20617142Free PMC article.Review.
- Vesicular stomatitis virus-based Ebola vaccines with improved cross-protective efficacy.Marzi A, Ebihara H, Callison J, Groseth A, Williams KJ, Geisbert TW, Feldmann H.Marzi A, et al.J Infect Dis. 2011 Nov;204 Suppl 3(Suppl 3):S1066-74. doi: 10.1093/infdis/jir348.J Infect Dis. 2011.PMID:21987743Free PMC article.
- Tackling Ebola: new insights into prophylactic and therapeutic intervention strategies.de Wit E, Feldmann H, Munster VJ.de Wit E, et al.Genome Med. 2011 Jan 27;3(1):5. doi: 10.1186/gm219.Genome Med. 2011.PMID:21349211Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical